158 related articles for article (PubMed ID: 1719244)
1. Biopsy after external beam radiation therapy for adenocarcinoma of the prostate: correlation with original histological grade and current prostate specific antigen levels.
Dugan TC; Shipley WU; Young RH; Verhey LJ; Althausen AF; Heney NM; McManus PL; Abraham EH
J Urol; 1991 Nov; 146(5):1313-6. PubMed ID: 1719244
[TBL] [Abstract][Full Text] [Related]
2. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma.
Stock RG; Stone NN; DeWyngaert JK; Lavagnini P; Unger PD
Cancer; 1996 Jun; 77(11):2386-92. PubMed ID: 8635111
[TBL] [Abstract][Full Text] [Related]
3. Effect of external beam radiation therapy on serum prostate-specific antigen.
Chodak GW; Neumann J; Blix G; Sutton H; Farah R
Urology; 1990 Apr; 35(4):288-94. PubMed ID: 1690936
[TBL] [Abstract][Full Text] [Related]
4. [Echo-guided biopsy of the transitional zone in the diagnosis of prostatic carcinoma].
Pagliarulo A; Curatolo C; Cirillo Marucco E; Lorusso A; Limitone DA; Ludovico GM
Arch Ital Urol Androl; 1996 Dec; 68(5 Suppl):221-4. PubMed ID: 9162367
[TBL] [Abstract][Full Text] [Related]
5. Teletherapy for stage C adenocarcinoma of the prostate.
Lupu AN; Petrovich Z; Corvalan J; Katske FA; Kaufman JJ
J Urol; 1982 Jul; 128(1):75-8. PubMed ID: 7109076
[TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of trans-rectal ultrasound, biopsy, and serum prostate-specific antigen following external beam radiotherapy for carcinoma of the prostate.
Crook J; Robertson S; Collin G; Zaleski V; Esche B
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(1):31-7. PubMed ID: 7690016
[TBL] [Abstract][Full Text] [Related]
7. Nondetectable prostate-specific antigen in moderately differentiated adenocarcinoma of prostate.
Daugherty RL; Cos LR; Keller JW; di Sant'Agnese A
Urology; 1992 Jun; 39(6):552-5. PubMed ID: 1377434
[TBL] [Abstract][Full Text] [Related]
8. Prostate specific antigen as an outcome variable for T1 and T2 prostate cancer treated by radiation therapy.
Zagars GK
J Urol; 1994 Nov; 152(5 Pt 2):1786-91. PubMed ID: 7523725
[TBL] [Abstract][Full Text] [Related]
9. Frequency of residual neoplasm in the prostate following three-dimensional conformal radiotherapy.
Forman JD; Oppenheim T; Liu H; Montie J; McLaughlin PW; Porter AT
Prostate; 1993; 23(3):235-43. PubMed ID: 7694267
[TBL] [Abstract][Full Text] [Related]
10. The influence of percentage of preradiation needle biopsies with adenocarcinoma and total radiation dose on the pathologic response of unfavorable prostate adenocarcinoma.
Goldstein NS; Kestin LL; Vicini FA; Martinez AA
Am J Clin Pathol; 2002 Jun; 117(6):927-34. PubMed ID: 12047145
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of radiation effect, tumor differentiation, and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma.
Crook JM; Bahadur YA; Robertson SJ; Perry GA; Esche BA
Cancer; 1997 Jan; 79(1):81-9. PubMed ID: 8988730
[TBL] [Abstract][Full Text] [Related]
12. Prostate specific antigen nadir following external beam radiation therapy for clinically localized prostate cancer: the relationship between nadir level and disease-free survival.
Lee WR; Hanlon AL; Hanks GE
J Urol; 1996 Aug; 156(2 Pt 1):450-3. PubMed ID: 8683700
[TBL] [Abstract][Full Text] [Related]
13. Do prostatic biopsies 12 months or more after external irradiation for adenocarcinoma, Stage III, predict long-term survival?
Cox JD; Kline RW
Int J Radiat Oncol Biol Phys; 1983 Mar; 9(3):299-303. PubMed ID: 6404866
[TBL] [Abstract][Full Text] [Related]
14. Systematic biopsies: do they add prognostic information in men with clinically localized prostate cancer treated with radiation therapy alone?
Lee WR; Hanlon AL; Hanks GE
Radiology; 1996 Feb; 198(2):439-42. PubMed ID: 8596846
[TBL] [Abstract][Full Text] [Related]
15. Outcome evaluation of the 1997 American Joint Committee on Cancer staging system for prostate carcinoma treated by radiation therapy.
Iyer RV; Hanlon AL; Pinover WH; Hanks GE
Cancer; 1999 Apr; 85(8):1816-21. PubMed ID: 10223577
[TBL] [Abstract][Full Text] [Related]
16. The significance of needle biopsy after irradiation for stage C adenocarcinoma of the prostate.
Cox JD; Stoffel TJ
Cancer; 1977 Jul; 40(1):156-60. PubMed ID: 406978
[TBL] [Abstract][Full Text] [Related]
17. The clinical significance of persistent cancer cells on prostate biopsy after high-dose-rate brachytherapy boost for intermediate-risk prostate cancer.
D'Alimonte L; Helou J; Sherman C; Loblaw A; Chung HT; Ravi A; Deabreu A; Zhang L; Morton G
Brachytherapy; 2015; 14(3):309-14. PubMed ID: 25466361
[TBL] [Abstract][Full Text] [Related]
18. Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome.
Zietman AL; Coen JJ; Shipley WU; Willett CG; Efird JT
J Urol; 1994 Mar; 151(3):640-5. PubMed ID: 7508522
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy for localized prostate carcinoma. The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen.
Crook JM; Bahadur YA; Bociek RG; Perry GA; Robertson SJ; Esche BA
Cancer; 1997 Jan; 79(2):328-36. PubMed ID: 9010106
[TBL] [Abstract][Full Text] [Related]
20. Prostate-specific antigen and external beam radiation therapy in prostate cancer.
Zagars GK; Sherman NE; Babaian RJ
Cancer; 1991 Jan; 67(2):412-20. PubMed ID: 1702349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
